Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

The high burden and growing prevalence of invasive fungal infections (IFIs), the toxicity and
interactions associated with current antifungal drugs, as well as the increasing resistance …

These updated AST‐IDCOP guidelines provide information on epidemiology, diagnosis, and
management of Aspergillus after organ transplantation. Aspergillus is the most common …

Purpose: The increasing burden of invasive fungal infections results in growing challenges
to antifungal (AF) therapeutic drug monitoring (TDM). This review aims to provide an …

In recent decades, important advances have been made in the diagnosis and treatment of
invasive aspergillosis (IA) and mucormycosis. One of these advances has been the …

Mucormycosis is a rare but life-threatening fungal infection due to molds of the order
Mucorales. The incidence has been increasing over recent decades. Worldwide, pulmonary …

Clinical use of voriconazole, posaconazole, and itraconazole revealed the need for
therapeutic drug monitoring (TDM) of plasma concentrations of these antifungal agents. This …

Background Isavuconazole (ISA) is an attractive candidate for primary mold-active
prophylaxis in high-risk patients with hematologic malignancies or hematopoietic cell …

Isavuconazole is a triazole antifungal agent recently recommended as first-line therapy for
invasive pulmonary aspergillosis. With the COVID-19 pandemic, cases of COVID-19 …

Background The broad‐spectrum triazole isavuconazole is used for the treatment of invasive
aspergillosis and mucormycosis. Data regarding human plasma concentrations in clinical …